Back to search

Netherlands· NL-529fd42de6c6

Bixocel 100 mg, capsules, hard

A celecoxib product containing celecoxib, registered in Netherlands by Synthon B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC M01AH01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedBixocel 100 mg, capsules, hardATCM01AH01REGISTER NO.NL-529fd42de6c6PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Celecoxib is registered in 13 of 19 countries.

Countries holding a registration under ATC M01AH01 (celecoxib), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Celecoxib · ATC M01AH01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of celecoxib costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.40 in Italy to $1.31 in Switzerland — a ×3.3 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Celecoxib · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.31
  • ES Spain$0.85
  • IT Italy$0.40
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CELECOXIB
Manufacturer
Synthon B.V.
Country
Netherlands (NL)
ATC code
M01AH01
ATC class
Celecoxib
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    112744

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

778 interactions on record for celecoxib.

Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Celecoxib · interactions on record

778 records

  • 36 severe
  • 349 moderate
  • 4 minor
  • 360 info

Most severe, free to view

  • EliglustatA16AX10severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • CimetidineA02BA01moderate

29 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Celecoxib in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All celecoxib products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Celebrex, Celecoxib Ratiopharm
  • Belgium · Celebrex, Celecoxib Ab
  • Bulgaria · Аклекса, Дефинакс
  • Cyprus · Celebrex, Celecoxib Accord
  • Czechia · Aclexa, Celebrex
  • Germany · Celebrex, Celecaxiro
  • Denmark · Celebra, Celecoxib Accord
  • Estonia · Aclexa, Celebrex
  • Spain · Artilog, Axatal
  • Finland · Celebra, Celecoxib Krka
  • France · Celebrex, Celecoxib Arrow Lab
  • United Kingdom (Northern Ireland) · Celebrex, Celecoxib
  • Greece · Celebrex
  • Croatia · Aclexa, Celixib
  • Hungary · Aclexa, Celebrex
  • Ireland · Celebrex, Celecoxib Accord Healthcare Ireland
  • Iceland · Celebra, Celecoxib Actavis
  • Italy · Celartrox, Celebrex
  • Lithuania · Aclexa, Celecoxib Accord
  • Luxembourg · Celebrex, Celecoxib Eg
  • Latvia · Celebrex, Celecoxib Inteli
  • Malta · Aclexa, Celebrex
  • Norway · Celebra, Celecoxib Accord
  • Poland · Aclexa, Celebrex
  • Portugal · Celebrex, Celecoxib Alter
  • Romania · Aclexa, Capsule Teva
  • Sweden · Celebra, Celecoxib Accord
  • Slovenia · Aclexa, Celebrex
  • Slovakia · Aclexa, Celebrex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f837fe17-c4a1-44dd-b703-5c826e6be472
GET /v1/drugs/f837fe17-c4a1-44dd-b703-5c826e6be472?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h112744_smpc.pdf",
  "strength": null,
  "atc_label": "Celecoxib",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg112744",
  "excipients": [
    "AMMONIA (E 527)",
    "BLAUWE INKT",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "GELATINE (E 441)",
    "IJZEROXIDE GEEL (E 172)",
    "INDIGOKARMIJN ALUMINIUMLAK (E 132)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMLAURILSULFAAT",
    "POVIDON K 30 (E 1201)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK (E 904)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "CELECOXIB"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h112744.pdf",
  "authorised_at": "2014/05/26",
  "procedure_number": "NL/H/2796/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "112744",
  "additional_monitoring": "N"
}

See everything about celecoxib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.